Applied DNA Sciences Inc (APDN)

[Shail]

WT,

From my call with Debbie about a fortnight ago, it was clear that they are going for the RS as soon as it is approved in the meeting on the 28th of Aug.

She had said that once approved, it could take them about a month to complete some listing formalities before they can be listed on either the Nasdaq or NYSE. Hence I doubt whether that can happen before the conference on 8th Sept.

This brings to a point about the RS. Is the management's interest genuinely to uplist or is it just to do a RS and get the price above $4/- I say this because many of us have presented conditions for uplisting which require the company to be profitable, which we are not. Regarding investment from larger funds/institutions APDN can meet the price condition of 4/5 dollars by simply doing a RS. Is being listed also a condition. Maybe not. This whole uplisting logic may be given to us only so that we approve.

Would love someone to throw some light on this.